{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:26:31Z","timestamp":1760865991406},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cld.2016.02.015","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T04:06:57Z","timestamp":1464667617000},"page":"509-519","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute Alcoholic Hepatitis: Therapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Paulina K.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Lucey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2016.02.015_bib1","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMra1407298","article-title":"Recognition and management of withdrawal delirium (delirium tremens)","volume":"371","author":"Schuckit","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.02.015_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cgh.2014.07.060","article-title":"Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis","volume":"13","author":"O\u2019Leary","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.02.015_bib3","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.02.015_bib4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A\u00a0histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.02.015_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02235538","article-title":"Natural history of alcoholic hepatitis. I.\u00a0The acute disease","volume":"16","author":"Lischner","year":"1971","journal-title":"Am J Dig Dis"},{"issue":"1","key":"10.1016\/j.cld.2016.02.015_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.25952","article-title":"Rescue liver transplantation for severe alcoholic hepatitis: arriving where we started?","volume":"57","author":"Forrest","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.02.015_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(84)90776-9","article-title":"Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis","volume":"76","author":"Mendenhall","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2016.02.015_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabr\u00e9","year":"2000","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2016.02.015_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007749.pub2","article-title":"Antioxidant supplements for liver diseases","author":"Bjelakovic","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.cld.2016.02.015_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008344.pub2","article-title":"Nutritional support for liver disease","author":"Koretz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cld.2016.02.015_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.02.015_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.02.015_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0168-8278(12)61033-2","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","author":"Mathurin","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.02.015_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cld.2016.02.015_bib15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2016.02.015_bib16","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.02.015_bib17","series-title":"Product information: TRENTAL(R) oral tablets, pentoxifylline oral tablets","year":"2012"},{"key":"10.1016\/j.cld.2016.02.015_bib18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2016.02.015_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007339.pub2","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.cld.2016.02.015_bib20","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2016.02.015_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.02.015_bib22","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.02.015_bib23","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A\u00a0randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2016.02.015_bib24","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A\u00a0double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.02.015_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI5584","article-title":"Alcohol-induced generation of lipid peroxidation products in humans","volume":"104","author":"Meagher","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2016.02.015_bib26","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus n-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.02.015_bib27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.02.015_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A\u00a0randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.02.015_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A\u00a0randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2016.02.015_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002235.pub2","article-title":"S-adenosyl-L-methionine for alcoholic liver diseases (Review)","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2016.02.015_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2016.02.015_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"key":"10.1016\/j.cld.2016.02.015_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cld.494","article-title":"The gut microbiome in NAFLD and ALD","volume":"6","author":"Kirpich","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2016.02.015_bib34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2016.02.015_bib35","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.02.015_bib36","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2016.02.015_bib37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the United States - a single center experience","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.02.015_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.478","article-title":"Palliative care for patients with end-stage liver disease: an overview","volume":"6","author":"Rakoski","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2016.02.015_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cld.479","article-title":"A\u00a0\u201cgood death\u201d with irreversible liver disease: talking with patients and families about deteriorating health and dying","volume":"6","author":"Boyd","year":"2015","journal-title":"Clin Liver Dis"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116300150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116300150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T15:00:52Z","timestamp":1536678052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326116300150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1089326116300150"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2016.02.015","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Alcoholic Hepatitis: Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2016.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}